02/10/2026
NHS Supply Chain has just revealed a new tranche of 78 medical devices being considered for their "Core List". This is a critical development for all players in the healthcare industry.
Key devices under assessment:
- Digital blood pressure devices
- Urine catheters
- Stoma bags
- Oxygen masks
- Protective garments
- Wound dressings
- Defibrillator pads
- Medical watches
The inclusion of these products aims to leverage the NHS' national buying power, streamline the purchasing process, and enhance cost efficiency and supply resilience.
What impact does this have on patients?
For patients, this initiative translates to potential improvements in the availability and affordability of essential medical devices. Streamlined purchasing and enhanced supply chain resilience mean that patients can expect more reliable access to critical health products, which can lead to improved health outcomes and a more consistent standard of care.
How are you gearing up for these changes?
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, and a Trustee of the Bios Centre for bioethics shares the latest list of medical devices being assessed for inclusion in the “Core List” of products available to the NHS ...